Zhi-Ping Zhuang

This inventor holds 11 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of Pennsylvania. Active years: 2004-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhi-Ping Zhuang. Retrieved from https://idiyas.com/inventor/zhi-ping-zhuang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 72.7

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 99(Granted Patents)

Company Filing History:

11 out of 2,659

University of Pennsylvania

patents

Years Active: 2004-2013

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE44354 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2013-07-08),

2. RE44338 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2013-07-01),

3. 8465726 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2013-06-18),

4. 7858072 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2010-12-28),

5. 7807135 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2010-10-05),

6. 7759502 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2010-07-20),

7. 7425318 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2008-09-16),

8. 7297820 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2007-11-20),

9. 7250525 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2007-07-31),

10. 6946116 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2005-09-20),

11. 6696039 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2004-02-24),

Title: **Zhi-Ping Zhuang: Innovator in Amyloid Research**

Introduction

Zhi-Ping Zhuang is an esteemed inventor based in Lansdale, Pennsylvania. With a remarkable portfolio of 11 patents, he has significantly contributed to the field of biomedical research, particularly in the study of amyloid deposits and their implications in various diseases.

Latest Patents

Among his most recent inventions are the "Amyloid plaque aggregation inhibitors and diagnostic imaging agents." This innovative technology encompasses a method for effectively imaging amyloid deposits. It utilizes labeled compounds and methods to create these compounds that serve as critical tools in diagnosing diseases associated with amyloid aggregation. Additionally, Zhuang's work includes developing compounds that inhibit the aggregation of amyloid proteins, offering potential therapeutic delivery methods to target amyloid deposits directly.

Career Highlights

Zhi-Ping Zhuang is affiliated with the University of Pennsylvania, where he works at the forefront of research and development within his field. His academic background and focus on amyloid research have positioned him as an essential contributor to the understanding of amyloid-related conditions, inspiring further advancement in diagnostic and therapeutic strategies.

Collaborations

Throughout his career, Zhuang has collaborated with notable researchers, including colleagues Hank F Kung and Mei-Ping Kung. These partnerships have played a vital role in the success of his research endeavors, leading to innovative solutions in combating amyloid-related diseases.

Conclusion

Zhi-Ping Zhuang's contributions to the field of amyloid research showcase the importance of innovation in medical science. His patented inventions not only advance diagnostic methods but also pave the way for new therapeutic approaches, reinforcing the impact of dedicated inventors in addressing complex health challenges.

Profile summary based on public USPTO records.